IonQ, H&E Equipment Services And ImmunityBio Are Among Top Mid Cap Gainers Last Week (Jan 13-Jan 17): Are The Others In Your Portfolio? - ImmunityBio (NASDAQ:IBRX), IonQ (NYSE:IONQ)

These eight mid-cap stocks were the best performers in the last week. Are they in your portfolio?

Read Next:

MicroStrategy, SoFi Technologies And Carvana Are Among Top Large-Cap Gainers Last Week (Jan 13-Jan 17): Are The Others In Your Portfolio?
Moderna, GameStop And Snap Are Among Top Large-Cap Losers Last Week (Jan 13-Jan 17): Are The Others In Your Portfolio?

Image via Shutterstock

Market News and Data brought to you by Benzinga APIs

To add Benzinga News as your preferred source on Google, click here.

These eight mid-cap stocks were the best performers in the last week. Are they in your portfolio?

H&E Equipment Services, Inc. (NASDAQ:HEES) shares rocketed 100.59% after United Rentals, Inc. (NYSE:URI) announced it would acquire the company for around $4.8 billion. UBS downgraded H&E Equipment to Neutral from Buy and raised the price forecast to $92 from $60.
SEMrush Holdings, Inc. (NYSE:SEMR) shares jumped 36.17%, probably due to overall market strength after CPI data was in line with estimates and core CPI rose by less than expected. Also, Morgan Stanley upgraded the company to Overweight from Equal-Weight and raised the price forecast to $20 from $17.
Compass, Inc. (NYSE:COMP) shares upped 26.36% after the company raised its fourth-quarter and FY24 guidance.
Blueprint Medicines Corporation (NASDAQ:BPMC) shares grew 25.87% after the company reported a year-over-year increase in FY24 AYVAKIT revenue results.
Alignment Healthcare, Inc. (NASDAQ:ALHC) stock grew 22.73%.
Option Care Health, Inc. (NASDAQ:OPCH) shares gained 21.55% last week after the company approved a new $500 million stock repurchase program and issued FY24 adjusted EPS guidance above estimates. Barrington Research maintains Option Care Health with an Outperform rating and raised the price forecast from $32 to $33.
ImmunityBio, Inc.'s (NASDAQ:IBRX) stock escalated 21.49% on updates on its ongoing FDA discussions regarding three areas of its clinical development pipeline: non-muscle invasive bladder cancer (NMIBC) and non-small cell lung cancer (NSCLC).
IonQ, Inc. (NYSE:IONQ) stock surged 20.29% after Microsoft Corporation (NASDAQ:MSFT) issued a statement to its business customers to get "quantum ready" and NVIDIA Corp (NASDAQ:NVDA) announced its first-ever quantum day event.